Healthways, Inc. (NASDAQ:TVTY) Director Conan Laughlin sold 115,087 shares of the business’s stock in a transaction that occurred on Wednesday, November 15th. The shares were sold at an average price of $33.87, for a total value of $3,897,996.69. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.
Conan Laughlin also recently made the following trade(s):
- On Friday, November 17th, Conan Laughlin sold 490,000 shares of Healthways stock. The shares were sold at an average price of $34.34, for a total value of $16,826,600.00.
- On Monday, November 6th, Conan Laughlin sold 120,000 shares of Healthways stock. The shares were sold at an average price of $47.52, for a total value of $5,702,400.00.
Shares of Healthways, Inc. (TVTY) opened at $34.75 on Monday. The company has a debt-to-equity ratio of 0.02, a quick ratio of 0.60 and a current ratio of 0.60. Healthways, Inc. has a 12 month low of $20.60 and a 12 month high of $48.50. The firm has a market capitalization of $1,376.69, a price-to-earnings ratio of 21.19, a price-to-earnings-growth ratio of 1.97 and a beta of 0.27.
Healthways (NASDAQ:TVTY) last released its earnings results on Thursday, October 26th. The company reported $0.46 earnings per share for the quarter, topping the consensus estimate of $0.36 by $0.10. Healthways had a return on equity of 30.23% and a net margin of 11.45%. The firm had revenue of $137.70 million during the quarter, compared to analysts’ expectations of $137.95 million. Healthways’s revenue was up 10.2% compared to the same quarter last year. equities analysts anticipate that Healthways, Inc. will post 1.6 EPS for the current fiscal year.
COPYRIGHT VIOLATION WARNING: This piece was originally posted by StockNewsTimes and is the sole property of of StockNewsTimes. If you are reading this piece on another website, it was illegally copied and reposted in violation of US & international copyright laws. The legal version of this piece can be read at https://stocknewstimes.com/2017/11/20/insider-selling-healthways-inc-tvty-director-sells-3897996-69-in-stock.html.
Several institutional investors and hedge funds have recently made changes to their positions in the company. Neuberger Berman Group LLC lifted its stake in shares of Healthways by 587.7% in the 3rd quarter. Neuberger Berman Group LLC now owns 1,633,016 shares of the company’s stock valued at $66,627,000 after acquiring an additional 1,395,539 shares during the last quarter. Sawgrass Asset Management LLC lifted its stake in shares of Healthways by 31.6% in the 3rd quarter. Sawgrass Asset Management LLC now owns 7,755 shares of the company’s stock valued at $316,000 after acquiring an additional 1,860 shares during the last quarter. Chartwell Investment Partners LLC lifted its stake in shares of Healthways by 194.6% in the 3rd quarter. Chartwell Investment Partners LLC now owns 111,754 shares of the company’s stock valued at $4,559,000 after acquiring an additional 73,819 shares during the last quarter. Lbmc Investment Advisors LLC lifted its stake in shares of Healthways by 296.3% in the 3rd quarter. Lbmc Investment Advisors LLC now owns 30,477 shares of the company’s stock valued at $1,243,000 after acquiring an additional 22,787 shares during the last quarter. Finally, SG Americas Securities LLC bought a new position in shares of Healthways in the 3rd quarter valued at $210,000.
Several brokerages recently issued reports on TVTY. Oppenheimer Holdings, Inc. boosted their price target on Healthways from $47.00 to $50.00 and gave the company an “outperform” rating in a research note on Wednesday, November 1st. SunTrust Banks, Inc. set a $50.00 price target on Healthways and gave the company a “buy” rating in a research note on Friday, October 27th. Zacks Investment Research upgraded Healthways from a “hold” rating to a “buy” rating and set a $52.00 price target for the company in a research note on Tuesday, October 31st. ValuEngine cut Healthways from a “buy” rating to a “hold” rating in a research note on Monday, October 2nd. Finally, Chardan Capital reiterated a “neutral” rating and issued a $44.00 price target (up from $40.00) on shares of Healthways in a research note on Friday, October 27th. Two analysts have rated the stock with a hold rating, seven have issued a buy rating and one has assigned a strong buy rating to the stock. Healthways currently has a consensus rating of “Buy” and a consensus price target of $46.25.
Tivity Health, Inc, formerly Healthways, Inc, is focused targeted population health for those aged 50 and older. The Company offers three programs: SilverSneakers senior fitness, Prime fitness and WholeHealth Living. The SilverSneakers senior fitness program is offered to members of Medicare Advantage, Medicare Supplement, and Group Retiree plans.
Receive News & Ratings for Healthways Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthways Inc. and related companies with MarketBeat.com's FREE daily email newsletter.